指标组别

IL-2

IL-4

IL-6

IL-10

IFN-g

TNF-α

研究组 (39例)

治疗前

88.16 ± 4.58

17.27 ± 2.23

1.71 ± 0.43

8.21 ± 1.38

29.29 ± 2.57

26.32 ± 3.01

治疗后

97.00 ± 4.25

12.79 ± 2.19

1.69 ± 0.38

8.00 ± 1.06

36.68 ± 3.22

32.35 ± 3.02

差值

8.84 ± 3.37

−4.48 ± 2.39

−0.016 ± 0.41

−0.21 ± 1.16

7.54 ± 3.53

6.02 ± 2.83

t

−16.394

11.674

0.24

1.142

−14.648

−13.297

P

0.000

0.000

0.812

0.261

0.000

0.000

对照组 (38例)

治疗前

87.49 ± 5.21

17.24 ± 2.23

1.70 ± 0.47

8.21 ± 1.52

29.17 ± 2.27

26.17 ± 2.55

治疗后

92.15 ± 5.04

14.52 ± 2.05

1.69 ± 0.40

7.90 ± 1.30

33.23 ± 2.32

28.78 ± 2.36

差值

4.66 ± 3.78

−2.71 ± 1.72

−0.002 ± 0.43

−0.31 ± 1.11

4.06 ± 2.06

2.61 ± 2.42

t

−7.064

9.727

0.034

1.730

−12.153

−6.650

P

0.000

0.000

0.973

0.092

0.000

0.000

组间对比

t

5.117

−3.704

−0.141

0.381

5.290

5.682

P

0.000

0.000

0.888

0.704

0.000

0.000